Tom Caravela sits down with Ramin Farhood to discuss the intricacies of product launches within the pharmaceutical industry. They explore indicators of a successful launch and lessons learned from past challenges. The conversation delves into market access, reimbursement, and the critical impact of team alignment. Ramin highlights the balance between speed and safety, the importance of compliance, and the dangers of siloed operations. They also consider the role of digital and AI, patient insights, and provide practical advice for companies preparing for their first launch.

(0:00) Introduction and overview with Ramin Farhood

(0:17) Sponsor: Oncology Voice Network

(2:24) Ramin Farhood's career journey

(3:46) The significance of MAPS in Medical Affairs

(4:22) Key indicators of a successful product launch

(5:42) Insights from launch challenges and failures

(7:38) Market access and reimbursement in launches

(8:14) The effect of team alignment on launch outcomes

(10:33) Speed vs. safety in competitive product launches

(12:24) Compliance and medical governance roles

(16:17) The risks of siloed operations in product launches

(19:01) Overlooked elements in launch readiness

(24:02) Incorporating patient insights into strategy

(26:56) Digital and AI influence on launch approaches

(29:05) Tips for companies approaching their first launch

(30:36) The role of early education and real-world data

(31:47) Emphasizing early preparation and long-term vision

(31:59) Closing thoughts and appreciation